Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
247 studies found for:    Exclude Unknown | Expanded Access Studies
Show Display Options
Rank Status Study
1 No longer available Talent Aortic Cuff Stent Graft System Compassionate Use Registry
Condition: Abdominal Aortic Aneurysms
Intervention: Device: TALENT Aortic Cuff Abdominal Stent Graft
2 Approved for marketing Alglucosidase Alfa Temporary Access Program
Conditions: Glycogen Storage Disease Type II (GSD-II);   Pompe Disease (Late-Onset);   Acid Maltase Deficiency Disease;   Glycogenosis 2
Intervention: Biological: alglucosidase alfa (recombinant human acid alpha-glucosidase [rhGAA])
3 Available Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Sildenafil citrate
4 No longer available Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment
Condition: Renal Cell Carcinoma
Intervention: Drug: Axitinib
5 Available International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric Cancer
Conditions: Metastatic Gastric Cancer;   Metastatic Adenocarcinoma of the Gastroesophageal Junction
Intervention: Biological: Ramucirumab
6 Approved for marketing Early Access of MK0518 in Combination With an Optimized Background Antiretroviral Therapy (0518-023)
Condition: HIV Infections
Intervention: Drug: raltegravir
7 Available 131-I-MIBG Therapy for Refractory Neuroblastoma and Metastatic Pheochromocytoma
Conditions: Neuroblastoma;   Childhood Metastatic Pheochromocytoma
Interventions: Drug: 131 I-Metaiodobenzylguanidine (131 I-MIBG);   Drug: 131 I-MIBG
8 Approved for marketing Access Program With Denileukin Diftitox for the Treatment of Patients Currently Receiving Treatment With Commercially Available (Ontak)
Condition: Cancer
Intervention: Drug: Denileukin diftitox (ONTAK)
9 No longer available Emergency/Compassionate Use - AMPLATZER Duct Occluder
Conditions: Patent;   Ductus;   Arteriosus
Intervention: Device: Device closure with the AMPLATZER Duct Occluder
10 No longer available Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: sildenafil (Revatio) 20 mg TID
11 Available Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes
Conditions: Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE);   Juvenile Dermatomyositis (JDM);   Stimulator of Interferon Genes (STING)-Associated Vasculitis With Onset in Infancy (SAVI)
Intervention: Drug: Baricitinib
12 No longer available Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease
Conditions: Field Actinic Keratoses;   Basal Cell Carcinoma;   Bowen's Disease
Intervention: Drug: Metvix (methyl aminolevulinate)
13 Temporarily not available Standardization Research of TCM Syndrome Differentiation and Treatment on Advanced Breast Cancer
Conditions: Breast Cancer;   Bone Metastasis
Intervention: Dietary Supplement: Chinese Herbs
14 Available Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy
Condition: Colorectal Neoplasms
Intervention: Drug: Regorafenib (BAY73-4506)
15 Available Expanded Access WR 279396 Topical Cream Treatment for Uncomplicated Cutaneous Leishmaniasis
Condition: Leishmaniasis, Cutaneous
Intervention: Drug: WR 279,396
16 Available Influence of Preoperative Enema Application on Return of Gastrointestinal Function After Elective Cesarean Section: A Randomized Controlled Study
Conditions: Postoperative Bowel Sounds;   Bowel Gass Passage
Intervention: Drug: Fleet enema
17 Available Effect of American Ginseng on Exercise-induced Muscle Soreness
Condition: Exercise-induced Muscle Soreness
Intervention: Dietary Supplement: Ginseng
18 Available GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations
Condition: Obesity
Intervention: Drug: Liraglutide
19 Available Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma
Conditions: Recurrent Neuroblastoma;   Neuroblastoma
Interventions: Drug: Fenretinide Lym-X-Sorb Oral Powder;   Drug: Ketoconazole
20 No longer available A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation
Conditions: Irritable Bowel Syndrome With Constipation;   Chronic Idiopathic Constipation
Intervention: Drug: Tegaserod

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years